首页 正文

BMJ global health. 2024 Jun 10;9(6):e015079. doi: 10.1136/bmjgh-2024-015079 Q16.12025

Understanding the extent of economic evidence usage for informing policy decisions in the context of India's national health insurance scheme: Ayushman Bharat Pradhan Mantri Jan Aarogya Yojana (PM-JAY)

了解经济证据在印度国家健康保险方案(Ayushman Bharat PM-JAY)政策决策中的使用程度 翻译改进

Deepshikha Sharma  1, Akashdeep Singh Chauhan  1, Lorna Guinness  2, Abha Mehndiratta  2, Anamika Dhiman  2, Malkeet Singh  2, Shankar Prinja  3

作者单位 +展开

作者单位

  • 1 Department of Community Medicine and School of Public Health, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.
  • 2 Center for Global Development, London, UK.
  • 3 Department of Community Medicine and School of Public Health, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India shankarprinja@gmail.com.
  • DOI: 10.1136/bmjgh-2024-015079 PMID: 38857943

    摘要 Ai翻译

    Introduction: Ayushman Bharat Pradhan Mantri Jan Aarogya Yojana (PM-JAY) is one of the world's largest tax-funded insurance schemes. The present study was conducted to understand the decision-making process around the evolution (and revision) of health benefit packages (HBPs) and reimbursement rates within PM-JAY, with a specific focus on assessing the extent of use of economic evidence and role of various stakeholders in shaping these policy decisions.

    Methods: A mixed-methods study was adopted involving in-depth interviews with seven key stakeholders involved in HBP design and reimbursement rates decisions, and a survey of 80 government staff and other relevant stakeholders engaged in the implementation of PM-JAY. The data gathered were thematically analysed, and a coding framework was developed to explore specific themes. Additionally, publicly available documents were reviewed to ensure a comprehensive understanding of the decision-making processes.

    Results: Findings reveal a progressive transition towards evidence-based practices for policy decisions within PM-JAY. The initial version of HBP relied heavily on key criteria like disease burden, utilisation rates, and out-of-pocket expenditures, along with clinical opinion in shaping decisions around the inclusion of services in the HBP and setting reimbursement rates. Revised HBPs were informed based on evidence from a national-level costing study and broader stakeholder consultations. The use of health economic evidence increased with each additional revision with consideration of health technology assessment (HTA) evidence for some packages and reimbursement rates based on empirical cost evidence in the most recent update. The establishment of the Health Financing and Technology Assessment unit further signifies the use of evidence-based policymaking within PM-JAY. However, challenges persist, notably with regard to staff capacity and understanding of HTA principles, necessitating ongoing education and training initiatives.

    Conclusion: While substantial progress has been made in transitioning towards evidence-based practices within PM-JAY, sustained efforts and political commitment are required for the ongoing systematisation of processes.

    Keywords: Health economics; Health insurance; Health policies and all other topics; Health services research; India.

    Keywords:economic evidence; policy decisions; national health insurance; ayushman bharat

    Copyright © BMJ global health. 中文内容为AI机器翻译,仅供参考!

    相关内容

    期刊名:Bmj global health

    缩写:

    ISSN:2059-7908

    e-ISSN:2059-7908

    IF/分区:6.1/Q1

    文章目录 更多期刊信息

    全文链接
    引文链接
    复制
    已复制!
    推荐内容
    Understanding the extent of economic evidence usage for informing policy decisions in the context of India's national health insurance scheme: Ayushman Bharat Pradhan Mantri Jan Aarogya Yojana (PM-JAY)